drugset / Trial / NCT06265415

Comparative Study of Intravenous Labetalol Versus Intravenous Nitroglycerin Versus Sublingual Nifedipine

NCT06265415

Unknown 60 enrolled Sohag University
RandomizedParallel-groupOpen-labelTreatment

Summary

Pre-eclampsia (PE) is one of the most frequent pregnancy complications and is one of the main causes of maternal and fetal morbidity and mortality in its severe form.control of blood pressure is of crucial importance to avoid maternal and fetal complications.Therapeutic modalities that can target the underlying pathophysiological changes and reverse the endothelial dysfunction could help to ameliorate the systemic manifestations in patients with severe PE. Either Intravenous labetalol and nitroglycerine as well as sublingual nifedipine have been frequantly used for the management of acute severe hypertension in PE

Timeline

Start
2024-03-30
Primary completion
2025-03-30
Completion
2025-03-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Labetalol Small molecule 5 mg Intravenous
Comparator Nifedipine Other / unclassified 10 mg Other
Comparator nitroglycerine Unknown 4.8 mg Intravenous

Indications